Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Bachorik P, Rifkins B, Kwiterovich P. Lipids and dyslipoproteinemia. In: Henry JB, editor. Clinical diagnosis and management by laboratory methods. 19th ed. Philadelphia: WB Saunders; 1996. p. 208–36.
Ginsberg H, Goldberg I. Disorders of lipoprotein metabolism. In: Braunwald E, Fauci AS, Kasper DC, Hauser SL, Lonpo DC, Jameson JL, editors. Harrison’s principles of internal medicine. 15th ed. New York: McGraw-Hill; 2007. p. 2245–57.
- Atherothrombogenicity of lipoprotein(a): the debate.Am. J. Cardiol. 1998; 82: 26Q-33Q
- Correlation of serum lipoprotein(a) with the angiographic and clinical presentation of coronary artery disease.Am. J. Cardiol. 1999; 83: 583-585
- Lipoprotein(a), fibrin binding, and plasminogen activation.Arteriosclerosis. 1990; 10: 240
- Antifibrinolytic activity of apolipoprotein(a) in vivo: human apolipoprotein(a) transgenic mice are resistant to tissue plasminogen activator-mediated thrombolysis.Nat. Med. 1995; 1: 256
- Interaction of recombinant apolipoprotein(a) and lipoprotein(a) with macrophages.J. Clin. Invest. 1991; 87: 767
- Lipoprotein(a) and coronary heart disease a perspective case-control study in a general population sample of middle aged men.Br. Med. J. 1990; 301: 1248-1251
Dahlen GH. Potential significance of Lp(a) lipoprotein. In: Bearn AG, editor. Genetics of coronary heart disease. Oslo: Institute of Medical Genetics; 1992. p. 75–88.
- Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men.Am. J. Cardiol. 1992; 69: 1251-1254
- Lipoprotein(a) and coronary heart disease: a nested case-control study of Helsinki Heart Study Participants.Atherosclerosis. 1991; 89: 59-67
- A prospective study of lipoprotein(a) and risk of myocardial infarction.Circulation. 1993; 88: 1-261
- Lipoprotein(a) levels and risk of coronary heart disease in men. The lipids research clinics coronary primary preventive trial.J. Am. Med. Assoc. 1994; 271: 999-1003
- Association between lipoprotein(a) and progression of coronary artery disease in middle-aged men.Am. J. Cardiol. 1994; 73: 742-746
- Effect of weight loss on serum lipoprotein(a) concentrations in obese population.Clin. Chem. 1991; 37: 1191-1195
- The association between physical activity, cardiorespiratory fitness, and lipoprotein(a) concentrations in tri-ethnic sample of women: The cross-cultural activity participation study.Vasc. Med. 2001; 6: 15-21
- Differences in Lp(a) concentration and apo(a) polymorphs between black and white Americans.J. Lipid. Res. 1996; 37: 2569
- Potential new cardiovascular risk factors: left ventricular hypertrophy, homocysteine, lipoprotein(a), triglycerides, oxidative stress, and fibrinogen.Ann. Intern. Med. 1999; 131: 376-386
- Effects of a low-calorie, low-salt diet and treadmill exercise on atherosclerotic risk factors in obese African–American women.Am. J. Cardiol. 2002; 89: 1311-1313
Randall OS, Randall D. Menu for life: African–Americans get healthy, eat well, lose weight and live beautifully. New York (NY): Random House Inc.; 2003. p. 22.
- Effect of weight loss on serum lipoprotein(a) in an Obese population.Clin. Chem. 1991; 37: 1191-1195
- A prospective investigation of elevated lipoprotein(a) detected by electrophoresis and cardiovascular disease in women: The Framingham heart study.Circulation. 1994; 90: 1688-1695
- Exercise capacity and mortality among men referred for exercise testing.N. Engl. J. Med. 2002; 346: 793-801
- Physical fitness as a predictor of mortality among healthy, middle aged Norwegian men.N. Engl. J. Med. 1993; 328: 533-537
- The association of changes in physical-activity level and other lifestyle characteristics with mortality among men.N. Engl. J. Med. 1993; 328: 538-545
- Physical activity and lipoprotein metabolism: epidemiological evidence and clinical trials.Eur. J. Med. Res. 1997; 2: 259-264
- Effects of exercise on lipoprotein(a).Sports Med. 1999; 28: 11-24
- Exercise induced increase in lipoprotein(a).Atherosclerosis. 1996; 122: 97-104
- Lipoprotein(a) in edurance athletes and sedentary controls.Med. Sci. Sports Exerc. 1996; 28: 962-966
- Lipoprotein(a) does not participate in the early acute phase response to training or extreme physical activity and is unlikely to enhance any associated immediate cardiovascular risk.J. Clin. Pathol. 2002; 55: 280-285
- Increase of serum lipoprotein(a) levels during growth hormone therapy in normal short children.Eur. J. Pediatr. 1998; 157: 4-7
- Rapid increase in plasma growth hormone after low intensity resistance exercise with vascular occlusion.J. Appl. Physiol. 2000; 88: 61-65
- Growth hormone, IGF-I and testosterone response to resistive exercise.Med. Sci. Sports Exerc. 1992; 24: 1346-1352
- Lipoproteins and homocysteine as risk factors for atherosclerosis: assessment and treatment.Can. J. Cardiol. 1995; 11: 18C-23C
- Lipoprotein(a): a genetic risk factor for premature coronary heart disease.J. Am. Med. Assoc. 1992; 267: 3326-3329